Literature DB >> 33725982

Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: A case report.

Hao Wu1, Sensen Su, Lin Li, Li Zhang.   

Abstract

RATIONALE: Atypical hemolytic uremic syndrome (aHUS) is an uncommon and serious disease that manifests hemolytic anemia, thrombocytopenia, and acute kidney injury. Genetic complement abnormalities have been shown to be responsible. Compared with the aHUS caused by other mutated genes, aHUS secondary to CFB mutation in adults is extremely rare. We report an adult with CFB mutation developing aHUS. PATIENT CONCERNS: A 56-year-old man was admitted for 4-day history of nausea and fatigue, anuria for 2 days, and unconsciousness for 10 hours. DIAGNOSES: The patient presented with life-threatening anemia, thrombocytopenia, acute kidney injury, and nervous system abnormalities. The patient had schistocytes on the peripheral blood smear, increased lactate dehydrogenase (LDH), and plasma-free hemoglobin levels. The patient was later found to harbor a pathogenic variant in the CFB gene (C.1598A>G), and was diagnosed with aHUS and acute kidney injury. INTERVENTION: The patient was treated by plasmapheresis, continuous renal replacement therapy, blood transfusion, and anti-infective and antihypertensive treatment. OUTCOMES: After the treatment, the patient's consciousness returned to normal, and the hemoglobin, platelet, and serum creatinine recovered. The disease activity remained quiescent during the follow-up. LESSONS: A rare heterozygous variant c.1598A>G p.Lys 533Arg in the CFB gene, which was associated with adult-onset aHUS, was described and successfully treated. This case can help in understanding the early diagnosis and effective therapies of this rare disease.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33725982      PMCID: PMC7982152          DOI: 10.1097/MD.0000000000025069

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  19 in total

Review 1.  Diagnosis of complement alternative pathway disorders.

Authors:  Andrea Angioi; Fernando C Fervenza; Sanjeev Sethi; Yuzhou Zhang; Richard J Smith; David Murray; Jens Van Praet; Antonello Pani; An S De Vriese
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

2.  Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

Authors:  Fengxiao Bu; Tara Maga; Nicole C Meyer; Kai Wang; Christie P Thomas; Carla M Nester; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

3.  Complement factor B mutation-associated aHUS and myocardial infarction.

Authors:  Natália Noronha; Filipa Dias Costa; Andrea Dias; Alexandra Dinis
Journal:  BMJ Case Rep       Date:  2017-07-14

4.  IgM nephropathy - Successful treatment with rituximab.

Authors:  Faheemuddin Azher Ahmed; Ashraf El-Meanawy
Journal:  Saudi J Kidney Dis Transpl       Date:  2019 Jan-Feb

Review 5.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

6.  Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

Authors:  Elena Goicoechea de Jorge; Claire L Harris; Jorge Esparza-Gordillo; Luis Carreras; Elena Aller Arranz; Cynthia Abarrategui Garrido; Margarita López-Trascasa; Pilar Sánchez-Corral; B Paul Morgan; Santiago Rodríguez de Córdoba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-20       Impact factor: 11.205

7.  Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Authors:  Tara K Maga; Carla J Nishimura; Amy E Weaver; Kathy L Frees; Richard J H Smith
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

8.  Comprehensive Analysis of Complement Genes in Patients with Atypical Hemolytic Uremic Syndrome.

Authors:  Tao Zhang; Jianping Lu; Shaoshan Liang; Dachen Chen; Haitao Zhang; Caihong Zeng; Zhihong Liu; Huimei Chen
Journal:  Am J Nephrol       Date:  2016-04-12       Impact factor: 3.754

9.  Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome.

Authors:  C M Taylor; C Chua; A J Howie; R A Risdon
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

10.  Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?

Authors:  Maria Chiara Marinozzi; Laura Vergoz; Tania Rybkine; Stephanie Ngo; Serena Bettoni; Anastas Pashov; Mathieu Cayla; Fanny Tabarin; Mathieu Jablonski; Christophe Hue; Richard J Smith; Marina Noris; Lise Halbwachs-Mecarelli; Roberta Donadelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

View more
  1 in total

1.  Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation.

Authors:  Sai Samyuktha Bandaru
Journal:  Cureus       Date:  2022-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.